Local ablative therapy

Hepatocellular Carcinoma

Volumn , Issue , 2008, Pages 645-659

  Livraghi, Tito ^a  

^a Ospedale Civile   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 54049128043     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1142/9789812770059_0029     Document Type: Chapter

References (46)

1. Livraghi T, Festi D, Monti F, et al. (1986). US-guided percutaneous alcohol injection of small hepatic and abdominal tumors. Radiology 161:309-12.
2. Masters A, Steger AC, Lees WR (1992). Interstitial laser hyperthermia: a new approach for treating liver metastases. Br J Cancer 66:518-22.
3. Rossi S, Fornari F, Buscarini L (1993). Percutaneous ultrasound guided radiofrequency electrocautery for the treatment of small hepatocellular carcinoma. J Interv Radiol 8:97-103.
4. Ohnishi K, Ohyama M, Ito S, Fujiara K (1994). Ultrasound guided intratumor injection of acetic acid for the treatment of small hepatocellular carcinoma. Radiology 193:747-52.
5. Murakami R, Yoshimatsu S, Yamashita Y, et al. (1995). Treatment of hepatocellular carcinoma: value of percutaneous microwave coagulation. AJR Am J Roentgenol 164:1159-64.
6. Livraghi T, Vettori C, Torzilli G, et al. (1993). Percutaneous ethanol injection of hepatic tumors: single session therapy under general anesthesia. AJR Am J Roentgenol 160:1065-9.
7. Livraghi T, Giorgio A, Marin G, et al. (1995). Hepatocellular carcinoma and cirrhosis in 746 patients: long-term results of percutaneous ethanol injection. Radiology 197:101-8.
8. Livraghi T, Benedini V, Lazzaroni S, et al. (1998). Long term results of single session PEI in patients with large hepatocellular carcinoma. Cancer 83:48-57.
9. Livraghi T, Grigioni W, Mazziotti A, et al. (1990). Percutaneous ethanol injection of portal thrombosis in hepatocellular carcinoma: a new possible treatment. Tumori 76:394-7.
10. Ebara M, Otho M, Sugiura N, et al. (1990). Percutaneous ethanol injection for the treatment of small hepatocellular carcinoma: study of 95 patients. J Gastroenterol Hepatol 5:616-26.
11. Shiina S, Tagawa K, Niwa Y, et al. (1993). Percutaneous ethanol injection therapy for hepatocellular carcinoma: results in 146 patients. AJRAm J Roentgenol160:1023-8.
12. Lencioni R, Pinto F, Armillotta N, et al. (1997). Long-term results of percutaneous ethanol injection for hepatocellular carcinoma in cirrhosis: a European experience. Eur Radiol 7:514-9.
13. Gazelle GS, Goldberg SN, Solbiati L, Livraghi T (2000). Tumor ablation with radiofrequency energy. Radiology 217:633-46.
14. McGahan PJ, Dodd III DG (2001). Radiofrequency ablation of the liver: current status. AJRAm J Roentgenol 176:3-16.
15. Goldberg SN, Gazelle GS, Solbiati L, et al. (1996). Radiofrequency tissue ablation: increased lesion diameter with a perfusion electrode. Acad Radiol3:636-44.
16. Goldberg SN, Solbiati L, Hahn PF, et al. (1998). Large volume tissue ablation with radiofrequency by using a clustered, internally cooled electrode technique: laboratory and clinical experience in liver metastases. Radiology 209:371-9.
17. Rossi S, Garbagnati F, Lencioni R, et al. (2000). Percutaneous radiofrequency ablation of nonresectable hepatocellular carcinoma after occlusion of tumor blood supply. Radiology 217:119-26.
18. Livraghi T, Goldberg N, Lazzaroni S, et al. (1999). Small hepatocellular carcinoma: treatment with radio-frequency ablation versus ethanol injection. Radiology 210:655-61.
19. Rossi S, Buscarini E, Garbagnati F (1998). Percutaneous treatment of small hepatic tumors by an expandable RF needle electrode. AJR Am J Roentgenol170:1015-22.
20. Ikeda M, Okada S, Ueno H, et al. (2001). Radiofrequency ablation and percutaneous ethanol injection with small hepatocellular carcinoma: a comparative study. Jpn J Clin Oncol 31:322-6.
21. Livraghi T, Goldberg SN, Lazzaroni S, et al. (2000). Hepatocellular carcinoma: radio-frequency ablation of medium and large lesions. Radiology 214:761-8.
22. Tateishi R, Shiina S, Teratani T, et al. (2005). Percutaneous radiofrequency ablation for hepatocellular carcinoma. An analysis of 1000 cases. Cancer103:1201-9.
23. Chen MH, Wei Y, Yan K, et al. (2006). Treatment strategy to optimize radiofrequency ablation for liver malignancies. JVasc Interv Radiol 17:671-83.
24. Sala M, Llovet JM, Vilana R, et al. (2004). Initial response to percutaneous ablation predicts survival in patients with hepatocellular carcinoma. Hepatology40:1352-60.
25. Bruix J, Sherman M (2005). Management of hepatocellular carcinoma. Hepatology 42:1208-36.
26. Di StasiM, Buscarini L, Livraghi T, et al. (1997). Percutaneous ethanol injection in the treatment of hepatocellular carcinoma: a multicenter survey of evaluation practices and complication rates. ScandJ Gastroenterol 32:1168-73.
27. Kotoh K, Sakai H, Sakamoto S, et al. (1994). The effect of percutaneous ethanol injection therapy on small solitary hepatocellular carcinoma is comparable to that of hepatectomy. Am J Gastroenterol 89:194-8.
28. Livraghi T, Bolondi L, Buscarini L, et al. (1995). No treatment, resection and ethanol injection in hepatocellular carcinoma: a retrospective analysis of survival in 391 patients with cirrhosis. J Hepatol 22:522-6.
29. Ryu M, Shimamura Y, Kinoshita T, et al. (1997). Therapeutic results of resection, TAE and PEI in 3225 patients with hepatocellular carcinoma: a retrospective multicenter study. Jpn J Clin Oncol 27:251-7.
30. Yamamoto J, Okada S, Shimada K, et al. (2001). Treatment strategy for small hepatocellular carcinoma: comparison of long-term results after percutaneous ethanol injection and surgical resection. Hepatology 34:707-13.
31. Huang GT, Lee PH, Tsang YM, et al. (2005). Percutaneous ethanol injection versus surgical resection for the treatment of small hepatocellular carcinoma: a prospective study. Ann Surg 242:36-42.
32. Lencioni R, Allgaier HP, Cioni D, et al. (2003). Small hepatocellular carcinoma in cirrhosis: randomized comparison of radio-frequency thermal ablation versus ethanol injection. Radiology 228:235-40.
33. Omata M, Tateishi R, Yoshida H, Shiina S (2004). Treatment of hepatocellular carcinoma by percutaneous tumor ablation methods: ethanol injection therapy and radiofrequency ablation. Gastroenterology 127:S159-66.
34. Lin SM, Lin CJ, Lin CC, et al. (2004). Radiofrequency ablation improves prognosis compared with ethanol injection for hepatocellular carcinoma < or = 4cm. Gastroenterology 127:1714-23.
35. Chen MS, Li JQ, Zheng Y, et al. (2006). A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma. Ann Surg 243:321-8.
36. Lu MD, Kuang M, Liang LJ, et al. (2006). Surgical resection versus percutaneous thermal ablation for early-stage hepatocellular carcinoma: a randomized clinical trial. Zhonghua YiXue ZaZhi 86:801-5.
37. Livraghi T, Solbiati L, Meloni F, et al. (2003). Treatment of focal liver tumors with radio-frequency ablation: complications encountered in a multicenter study. Radiology 226:441-51.
38. Akahane M, Koga H, Kato N, et al. (2005). Complications of percutaneous radiofrequency ablation for hepato-cellular carcinoma: imaging spectrum and management. Radiographics 25(Suppl 1):S57-68.
39. Rhim H (2005). Complications of radiofrequency ablation in hepatocellular carcinoma. Abdom Imaging 30:409-18.
40. Livraghi T, Lazzaroni S, Meloni F, Solbiati L (2005). Risk of tumour seeding after percutaneous radiofrequency ablation for hepatocellular carcinoma. Br JSurg 92:856-8.
41. Nakashima O, Kojiro M (2001). Recurrence of hepatocellular carcinoma: multicentric occurrence or intrahepatic metastasis? Aviewpoint in terms ofpathology. JHepatobiliary Pancreat Surg 8:404-9.
42. Arii S, Teramoto K, Kawamura T, et al. (2001). Characteristics of recurrent hepatocellular carcinoma in Japan and our surgical experience. J Hepatobiliary Pancreat Surg 8:397-403.
43. Bruix J, Castells A, Bosch J, et al. (1996). Surgical resection of hepatocellular carcinoma in cirrhotic patients: prognosis value ofpreoperative portal pressure. Gastroenterology 3:1018-22.
44. Llovet JM, Bru C, Bruix J (1999). Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Dis 19:329-38.
45. Villa E, Moles A, Ferretti I, et al. (2000). Natural history of inoperable hepatocellular carcinoma: estrogen receptors’ status in the tumor is the strongest prognostic factor for survival. Hepatology 32:233-8.
46. Livraghi T, Meloni F, Corso R, Rampoldi A (2000). Comparison between RF ablation and TACE in the treatment of multifocal hepatocellular carcinoma: preliminary experience. Radiology A217:287-8.